Home / Market News / $OPCH

$OPCH news and market catalysts

The 18 most recent market catalysts affecting $OPCH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

18 catalysts 8 high impact 7 bullish 8 bearish Healthcare Services
Nov 4, 2026 Corporate Catalyst Bearish Impact 95
Option Care Health Reports Third Quarter 2026 Financial Results
Option Care Health (OPCH) announced its third-quarter 2026 financial results, showing modest revenue and earnings growth. However, the most significant disclosure is the definitive…
Oct 16, 2026 Market Technicals Bearish Impact 65
Top 3 Health Care Stocks That May Fall Off A Cliff In October
The filing identifies Option Care Health (OPCH), Pacira Biosciences (PCRX), and HealthStream (HSTM) as significantly overbought based on their RSI values exceeding 83. This technic…
Oct 9, 2026 Corporate Catalyst Bearish Impact 65
UBS Downgrades Option Care Health to Neutral, Lowers Price Target to $32.05
UBS analyst A.J. Rice downgraded Option Care Health (OPCH) from a 'Buy' to a 'Neutral' rating and simultaneously lowered the price target from $39 to $32.05. This action signals a …
Oct 7, 2026 Corporate Catalyst Bearish Impact 55
William Blair Downgrades Option Care Health to Market Perform
William Blair analyst Matt Larew downgraded Option Care Health (OPCH) from an 'Outperform' rating to 'Market Perform'. This change in rating indicates that the analyst no longer ex…
Oct 7, 2026 Corporate Catalyst Bearish Impact 65
This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Several prominent Wall Street analysts have downgraded their ratings for PJT Partners, Option Care Health, Caribou Biosciences, and Ambev SA. These downgrades, particularly the sig…
Oct 7, 2026 Corporate Catalyst Bearish Impact 65
Citizens Downgrades Option Care Health to Market Perform
Citizens analyst Constantine Davides downgraded Option Care Health (OPCH) from Market Outperform to Market Perform. This downgrade signals a less optimistic view from a financial i…
Oct 7, 2026 Corporate Catalyst Bearish Impact 55
Barrington Research Downgrades Option Care Health to Market Perform
Barrington Research analyst Michael Petusky downgraded Option Care Health (OPCH) from 'Outperform' to 'Market Perform.' This action signals a reduced confidence in the stock's abil…
Oct 7, 2026 Corporate Catalyst Neutral Impact 75
AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Are on Investors' Radars Today
The filing details specific catalysts driving investor interest in five companies. AMD's CEO's comments on sustained high AI demand and potential increased investment signal strong…
Oct 6, 2026 Corporate Catalyst Neutral Impact 95
Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread
Option Care Health (OPCH) is being acquired by Clayton Dubilier & Rice and McKesson Corp. (MCK) for $32.05 per share, a 37% premium over its October 5th closing price. This is a ma…
Oct 6, 2026 Corporate Catalyst Neutral Impact 95
McKesson Takes A Stake In Option Care — With An Option On The Rest
McKesson Corporation and CD&R are acquiring Option Care Health Inc. for $32.05 per share, valuing the company at $5.8 billion. This represents a substantial 37% premium for OPCH sh…
Oct 6, 2026 Macro/Central Bank Bullish Impact 65
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Scott Bessent Doubles Down on Iran Pressure— OPCH, PCVX, STZ in Focus (UPDATED)
The filing primarily discusses the positive pre-market performance of U.S. stock futures, driven by a combination of macro factors and specific company news. Geopolitical developme…
Oct 6, 2026 Corporate Catalyst Bullish Impact 95
CD&R, McKesson Agree To Acquire Option Care Health For $32.05 Per share
Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $32.05 per share, representing a significant premium for OPCH shareholders. This transaction will take Op…
Oct 6, 2026 Corporate Catalyst Bullish Impact 95
Option Care Health shares are trading higher following reports suggesting McKesson and Clayton Dubilier & Rice are nearing a deal to acquire the company.
The potential acquisition of Option Care Health (OPCH) by McKesson (MCK) and Clayton Dubilier & Rice is a major corporate catalyst. OPCH shares are reacting positively due to the e…
Oct 6, 2026 Corporate Catalyst Bullish Impact 95
Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
The primary event disclosed is the sharp increase in Option Care Health (OPCH) shares, driven by unconfirmed reports of an impending acquisition by McKesson and Clayton Dubilier & …
Oct 5, 2026 Corporate Catalyst Bullish Impact 95
Option Care Health shares are trading higher following reports suggesting McKesson and Clayton Dubilier & Rice are nearing a deal to acquire the company.
This headline represents a major corporate catalyst for Option Care Health, driving its shares significantly higher due to the typical acquisition premium. For McKesson, it signifi…
Jul 30, 2026 Corporate Catalyst Bearish Impact 60
Deutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24
Deutsche Bank's downgrade of Option Care Health (OPCH) from 'Buy' to 'Hold' and the reduction of its price target from $26 to $24 signals a diminished confidence in the company's n…
Jul 29, 2026 Corporate Catalyst Bullish Impact 75
Option Care Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.
This headline is a significant corporate catalyst for Option Care Health (OPCH), directly impacting its stock price positively due to strong financial performance and an improved o…
Jul 29, 2026 Corporate Catalyst Bullish Impact 92
Option Care Health Q2 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $1.442B Beat $1.419B Estimate
Option Care Health (OPCH) announced Q2 adjusted EPS of $0.45, surpassing the $0.43 consensus estimate, and sales of $1.442 billion, beating the $1.419 billion estimate. This perfor…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.